Development of Resistance

• De novo

  • up regulation of intrinsic PmrA efflux pump
  • spontaneous mutations in primary target which lowers the affinity of the fluoroquinolone and increases the MIC: parC or gyrA

Previous slide

Next slide

Back to first slide

View graphic version